Results for tag: "Postherpetic Neuralgia Drug"

Postherpetic Neuralgia (PHN) is a chronic pain condition caused by shingles, a viral infection of the nerve cells. It is a common complication of shingles and can last for months or even years after the shingles rash has healed. Treatment for PHN includes medications, such as anticonvulsants, antidepressants, and opioids, as well as nerve blocks and topical creams. The Postherpetic Neuralgia Drug market is a segment of the Central Nervous System Drugs market. It is composed of a variety of medications used to treat PHN, including anticonvulsants, antidepressants, and opioids. These drugs are used to reduce pain, improve sleep, and improve quality of life. Some companies in the Postherpetic Neuralgia Drug market include Pfizer, GlaxoSmithKline, Merck, Johnson & Johnson, and Novartis. These companies produce a variety of medications used to treat PHN, including anticonvulsants, antidepressants, and opioids. Show Less Read more